- Targeted stakeholdersIncreases public awareness, potentially reducing diagnostic delays and improving earlier identification of undiagnosed…
- Federal agenciesEncourages federal and philanthropic focus on expanding diagnostic programs and genomic research capacity.
- CommunitiesSupports patient advocacy groups and community support networks, increasing resources and visibility for affected famil…
Expressing support for the designation of Undiagnosed Awareness Month.
Referred to the House Committee on Oversight and Government Reform.
This House resolution expresses support for designating April as Undiagnosed Awareness Month and April 29 as Undiagnosed Day.
It highlights the Undiagnosed Diseases Network (UDN), the Undiagnosed Diseases Network Foundation (UDNF), NIH efforts including planned expansion, and the role of genomic sequencing and AI in diagnosing rare and undiagnosed conditions.
House resolutions are nonbinding and do not become public law; passage in both chambers as binding law is unlikely based on form and content.
Relative to its intended legislative type, this bill is a straightforward commemorative resolution that articulates the problem context and expresses support for recognizing an awareness month and day. It provides the expected level of specificity for a symbolic designation and appropriately omits implementation, funding, or enforcement mechanisms.
Liberals emphasize funding and equitable access; conservatives stress budget neutrality.
Who stands to gain, and who may push back.
- Targeted stakeholdersResolution is purely symbolic and contains no funding or legally binding requirements.
- Targeted stakeholdersMay raise public expectations for expanded clinical services without committed appropriations.
- Targeted stakeholdersCould shift limited research funding priorities toward undiagnosed disease programs.
Why the argument around this bill splits.
Liberals emphasize funding and equitable access; conservatives stress budget neutrality.
Likely strongly supportive as a compassionate, equity-oriented recognition of people with rare and undiagnosed diseases.
Views the resolution as a useful advocacy and awareness step that complements calls for greater NIH investment and equitable access to genomic diagnostics.
Generally favorable but cautious; sees value in awareness and coordination while watching costs and implementation.
Appreciates NIH-led, evidence-based approaches and the non-binding, supportive nature of a House resolution.
Likely supportive of the symbolic recognition of patients but cautious about implications for expanded federal programs.
Views the nonbinding resolution positively while wary of future calls for increased NIH spending or regulatory expansions tied to it.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
House resolutions are nonbinding and do not become public law; passage in both chambers as binding law is unlikely based on form and content.
- Whether the House schedules the resolution for a floor vote
- If a companion or similar Senate resolution is introduced
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Liberals emphasize funding and equitable access; conservatives stress budget neutrality.
House resolutions are nonbinding and do not become public law; passage in both chambers as binding law is unlikely based on form and conten…
Relative to its intended legislative type, this bill is a straightforward commemorative resolution that articulates the problem context and expresses support for recognizing an awareness month and day. It provides the e…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.